Daniel O'Mahony is a Partner at Seroba, which he joined in 2009. His background covers product development, strategic planning, licensing, corporate venturing and commercialisation, including corporate venture work at Elan Corporation from 1996 to 2003 and a partnership at Kernel Capital from 2008. He previously held academic appointments at Trinity College Dublin, the Weis Research Centre at Geisinger Clinic and University College Dublin, and established the Technology Transfer Office at University of Galway. He currently sits on the boards of Loci Orthopaedics, Perfuze, Ryme Medical and Quanta Dialysis Technologies. Prior board companies include Apica Cardiovascular, Covagen, Atlantic Therapeutics, Novate Medical, PQ Bypass and Stokes Bio, all acquired.
Education
Ph.D., National University of Ireland, Cork
Business degree in technology management, Smurfit Business School, University College Dublin
Previous Experience
Elan Corporation - corporate venture
Partner, Kernel Capital
University of Galway - established the Technology Transfer Office
Academic appointments at Trinity College Dublin, Geisinger Clinic and University College Dublin
Notable Investments
Loci OrthopaedicsPerfuzeRyme MedicalQuanta Dialysis TechnologiesApica CardiovascularCovagenAtlantic TherapeuticsNovate MedicalPQ BypassStokes BioMedLumics
Board Seats
Loci Orthopaedics
Perfuze
Ryme Medical
Quanta Dialysis Technologies
Career Timeline
1996
Joined corporate venture at Elan Corporation.
2001
Began advising and consulting to Kernel Capital.
2005
Established the Technology Transfer Office at University of Galway.
2008
Became Partner at Kernel Capital, focusing on life sciences investments.